Word

VELAVIGO

Status

Registered

Status Code

700

Status Date

Tuesday, December 12, 2023

Serial Number

90838630

Registration Number

7238766

Registration Date

Tuesday, December 12, 2023

Mark Type

4000

Filing Date

Tuesday, July 20, 2021

Published for Opposition

Tuesday, June 27, 2023

Trademark Owner History

VELAVIGO (SHANGHAI) LIMITED - Original Registrant
Li Jing - Original Applicant

Classifications

5 Chemical preparations for medical purposes used for treating tumors, ophthalmology diseases, cardiovascular diseases, immune diseases, metabolic diseases, blood diseases, diabetes, endocrine system diseases, reproductive system diseases, respiratory system diseases, central and peripheral nervous system diseases, cancer, autoimmune diseases, inflammation and antivirals; bulk drugs in the nature of pharmaceutical preparations, namely, for treating tumors, ophthalmology diseases, cardiovascular diseases, immune diseases, metabolic diseases, blood diseases, diabetes, endocrine system diseases, reproductive system diseases, respiratory system diseases, central and peripheral nervous system diseases, cancer, autoimmune diseases, inflammation and antivirals; diagnostic preparations for medical purposes; biochemical medicines, namely, for use in treating tumors, ophthalmology diseases, cardiovascular diseases, immune diseases, metabolic diseases, blood diseases, diabetes, endocrine system diseases, reproductive system diseases, respiratory system diseases, central and peripheral nervous system diseases, cancer, autoimmune diseases, inflammation and antivirals; diagnostic biomarker reagents for medical purposes; medicines for human purposes used for treating tumors, ophthalmology diseases, cardiovascular diseases, immune diseases, metabolic diseases, blood diseases, diabetes, endocrine system diseases, reproductive system diseases, respiratory system diseases, central and peripheral nervous system diseases, cancer, autoimmune diseases, inflammation and antivirals; pharmaceutical preparations used for treating tumors, ophthalmology diseases, cardiovascular diseases, immune diseases, metabolic diseases, blood diseases, diabetes, endocrine system diseases, reproductive system diseases, respiratory system diseases, central and peripheral nervous system diseases, cancer, autoimmune diseases, inflammation and antivirals; chemico-pharmaceutical preparations used for treating tumors, ophthalmology diseases, cardiovascular diseases, immune diseases, metabolic diseases, blood diseases, diabetes, endocrine system diseases, reproductive system diseases, respiratory system diseases, central and peripheral nervous system diseases, cancer, autoimmune diseases, inflammation and antivirals; drugs in the nature of pharmaceutical preparations for medical purposes used for treating tumors, ophthalmology diseases, cardiovascular diseases, immune diseases, metabolic diseases, blood diseases, diabetes, endocrine system diseases, reproductive system diseases, respiratory system diseases, central and peripheral nervous system diseases, cancer, autoimmune diseases, inflammation and antivirals; biological preparations for medical purposes used for treating tumors, ophthalmology diseases, cardiovascular diseases, immune diseases, metabolic diseases, blood diseases, diabetes, endocrine system diseases, reproductive system diseases, respiratory system diseases, central and peripheral nervous system diseases, autoimmune diseases, inflammation, cancer, and antivirals; chemical preparations for pharmaceutical purposes used for treating tumors, ophthalmology diseases, cardiovascular diseases, immune diseases, metabolic diseases, blood diseases, diabetes, endocrine system diseases, reproductive system diseases, respiratory system diseases, central and peripheral nervous system diseases, autoimmune diseases, inflammation, cancer, and antivirals; radioactive substances for medical purposes; gases for medical purposes; chemical conductors for electrocardiograph electrodes; semen for artificial insemination; disinfectants; solutions for contact lenses; media for bacteriological cultures; medicated sweets; dietetic foods and beverages adapted for medical use; depuratives for the body; pesticides; sanitary napkins; cotton for medical purposes; dental abrasives; diapers for pets

35 Publicity services; marketing services, namely, presentation of goods on communication media, for retail purposes; business management assistance; marketing; personnel recruitment; compilation of information into computer databases; accounting; sponsorship search; rental of vending machines; rental of sales stands; retail store services featuring pharmaceutical, veterinary and sanitary preparations and medical supplies; wholesale store services featuring pharmaceutical, veterinary and sanitary preparations and medical supplies; retail and wholesale store services for medicines; retail and wholesale store services for pharmaceutical preparations; retail and wholesale store services for sanitary preparations; retail and wholesale store services for medical supplies; retail and wholesale store services for veterinary medicines; retail and wholesale store services for veterinary preparations

44 Medical screening; genetic testing for medical purposes; medical analysis services for the diagnosis of cancer; medical services for the treatment of skin cancer; performing diagnosis of diseases; pharmaceutical advice; mental health therapy services; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; convalescent home services; food nutrition consultation; beauty salon services; animal breeding; plant nursery services; opticians' services; rental of sanitation facilities

42 Scientific research for medical purposes in the area of cancerous diseases; scientific investigations for medical purposes; quality control for others; surveying; chemical analysis; research in the field of chemistry; chemical research; chemical research services; chemical research and analysis; cosmetic research; biochemical research and analysis; conducting early evaluation in the field of new pharmaceuticals; drug discovery services; pharmaceutical product evaluation; pharmaceutical research services; research on the subject of pharmaceuticals; development of pharmaceutical preparations and medicines; research and development services in the field of antibodies; scientific research in the nature of conducting clinical trials for others; biotechnology research; biological research; biological research and analysis; biomedical research services; medical laboratory services; medical research; medical research services; meteorological information; material testing; industrial design; architectural services; dress designing; computer programming in the medical field; authenticating works of art; graphic arts design; cloud seeding; handwriting analysis; cartography services; rental of meters for the recording of energy consumption; business card design; graphic design of promotional materials

Trademark Events

Dec 12, 2023

Notice Of Registration Confirmation Emailed

Dec 12, 2023

Registered-Principal Register

Nov 5, 2023

Extension Of Time To Oppose Process - Terminated

Jul 24, 2023

Extension Of Time To Oppose Received

Jun 27, 2023

Official Gazette Publication Confirmation E-Mailed

Jun 27, 2023

Published For Opposition

Jun 7, 2023

Notification Of Notice Of Publication E-Mailed

May 23, 2023

Law Office Publication Review Completed

May 15, 2023

Approved For Pub - Principal Register

May 12, 2023

Teas/Email Correspondence Entered

May 12, 2023

Correspondence Received In Law Office

May 11, 2023

Teas Response To Suspension Inquiry Received

May 9, 2023

Suspension Checked ¿ To Attorney For Action

May 3, 2023

Automatic Update Of Assignment Of Ownership

Apr 26, 2023

Suspension Checked ¿ To Attorney For Action

Nov 23, 2022

Assigned To Examiner

Oct 24, 2022

Notification Of Letter Of Suspension E-Mailed

Oct 24, 2022

Letter Of Suspension E-Mailed

Oct 24, 2022

Suspension Letter Written

Oct 20, 2022

Teas/Email Correspondence Entered

Oct 20, 2022

Correspondence Received In Law Office

Oct 20, 2022

Teas Response To Office Action Received

Apr 21, 2022

Notification Of Non-Final Action E-Mailed

Apr 21, 2022

Non-Final Action E-Mailed

Apr 21, 2022

Non-Final Action Written

Apr 12, 2022

Assigned To Examiner

Oct 5, 2021

Preliminary/Voluntary Amendment - Entered

Oct 4, 2021

Assigned To Lie

Aug 17, 2021

Teas Voluntary Amendment Received

Sep 21, 2021

New Application Office Supplied Data Entered

Jul 23, 2021

New Application Entered